sulfinpyrazone has been researched along with allopurinol in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 69 (79.31) | 18.7374 |
1990's | 4 (4.60) | 18.2507 |
2000's | 7 (8.05) | 29.6817 |
2010's | 7 (8.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Gancitano, A; Pallalardo, A | 1 |
Mertz, DP | 1 |
Kleinschmidt, A; Schräpler, P; Schulz, E | 1 |
Emmerson, BT | 1 |
Simkin, PA | 1 |
McCarty, DJ | 1 |
Akaoka, I; Masuda, T; Nishida, Y; Nishizawa, T | 1 |
Gordon, GV; Schumacher, HR | 1 |
Fox, IH; Sinclair, DS | 1 |
Alvsaker, JO | 1 |
Lowenthal, DT | 1 |
Kelley, WN | 2 |
Naess, K | 1 |
Iimura, O; Nakata, T | 1 |
Koehler, PC; Patterson, RS; Suiter, DR | 1 |
Chaudhary, K; Kumar, A; Malaviya, AN; Singh, YN; Tripathy, S | 1 |
Burghardt, B; Cardell, M; Janero, DR; Lopez, R | 1 |
Schlapbach, P | 1 |
Lo, B | 1 |
Bertoli, L; Borghi, C; Busnardo, I; Zagnoni, P | 1 |
Elion, GB | 1 |
Zöllner, N | 1 |
Gutman, AB | 2 |
Krebs, A; Zürcher, K | 1 |
Sellers, E; Weser, JK | 1 |
Yü, T; Yu, TF | 1 |
Fanelli, GM; Weiner, IM | 1 |
Kersley, GD | 5 |
Bluestone, R; Campion, D; Klinenberg, JR; Whitehouse, M | 1 |
Gutman, AB; Yü, TF | 1 |
Mayr, E | 1 |
Goldfinger, SE | 1 |
Gottesbüren, H; Strohmeyer, G | 1 |
Kelley, WN; Wyngaarden, JB | 1 |
Akaoka, I; Yoshimura, T | 1 |
Ina, K; Ito, M; Suzuki, Y; Yamagami, I | 1 |
Mehta, DM; Morse, WI; Woodbury, JF | 1 |
Houpt, JB | 1 |
Scott, JT | 1 |
Glover, RP; Jackman, AE; Kuzell, WC; Seebach, LM | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR | 1 |
Günther, R; Knapp, E | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, M | 1 |
Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, MW | 1 |
Yu, TF | 1 |
Nyfos, L | 1 |
Burtonboy, G; Michotte, JL | 1 |
Riccitelli, ML | 1 |
Highton, TC; Palmer, DG | 1 |
Kuzell, WC | 1 |
Holländer, E; Schwarczmann, P | 1 |
Seegmiller, JE | 1 |
Houpt, JB; Ogryzlo, MA; Urowitz, MB; Weber, HM | 2 |
Goldfarb, E; Smyth, CJ | 1 |
Bartels, EC | 1 |
Gaines, LM | 1 |
Seebach, LM | 1 |
Champion, GD; Day, RO; Graham, GG; Lee, E | 1 |
Kelley, WN; Palella, TD | 1 |
Rodnan, GP | 1 |
Baiatova, KV | 1 |
Conaghan, PG; Day, RO | 1 |
Angelini, A; Caforio, AL; Casarotto, D; Dalla Volta, S; Feltrin, G; Gambino, A; Marchini, F; Pompei, E; Testolin, L; Tona, F | 1 |
Huang, TS; Lee, Y; Lu, FJ; Yang, ML | 1 |
GOLDFINGER, S; KLINENBERG, JR; SEEGMILLER, JE | 1 |
Avorn, J; Brookhart, MA; Levin, R; Solomon, DH | 1 |
Andrade, SE; Briesacher, BA; Fouayzi, H; Harrold, LR; Ockene, IS; Raebel, MA; Yood, RA | 1 |
Klivényi, P; Plangár, I; Szalárdy, L; Vécsei, L; Zádori, D | 1 |
Aviña-Zubieta, JA; Choi, HK; De Vera, MA; McCormick, N; Rai, SK; Sayre, EC; Shojania, K | 1 |
14 review(s) available for sulfinpyrazone and allopurinol
Article | Year |
---|---|
[Gout. Diagnosis--pathogenesis--therapy].
Topics: Allopurinol; Balneology; Benzofurans; Crystallization; Diagnosis, Differential; Exercise Therapy; Glomerular Filtration Rate; Gout; Probenecid; Sulfinpyrazone; Uric Acid; Urinary Calculi | 1978 |
Drug control of gout and hyperuricaemia.
Topics: Allopurinol; Arthritis; Chronic Disease; Colchicine; Gout; Humans; Indomethacin; Naproxen; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1978 |
Pharmacologic approach to the maintenance of urate homeostasis.
Topics: Allopurinol; Diuresis; Gout; Homeostasis; Humans; Kidney Tubules; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1975 |
[Gout: diagnosis and therapy].
Topics: Allopurinol; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Probenecid; Sulfinpyrazone | 1985 |
Drug interactions with coumarin anticoagulants. 2.
Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide | 1971 |
Milestones in the treatment of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Kidney Calculi; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1974 |
Principles of current management of primary gout.
Topics: Adult; Allopurinol; Diet Therapy; Female; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone | 1967 |
[Antarthritics. 41].
Topics: Acute Disease; Allopurinol; Antineoplastic Agents; Benzofurans; Colchicine; Female; Gout; Humans; Phenylbutazone; Pregnancy; Probenecid; Sulfinpyrazone; Uricosuric Agents; Vasodilator Agents; Zoxazolamine | 1969 |
Treatment of gout.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Gout; Humans; Indomethacin; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase; Xanthines | 1971 |
[What is certain in gout therapy?].
Topics: Acute Disease; Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Kidney Tubules; Probenecid; Purines; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1971 |
Drug treatment of gout.
Topics: Acute Disease; Allopurinol; Arthritis; Colchicine; Gout; Humans; Orotic Acid; Probenecid; Structure-Activity Relationship; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1971 |
Anti-rheumatic drug interactions.
Topics: Adrenergic beta-Antagonists; Allopurinol; Animals; Antacids; Anti-Inflammatory Agents; Anticoagulants; Cimetidine; Diuretics; Drug Combinations; Drug Interactions; Glucocorticoids; Gold; Humans; Hypoglycemic Agents; Penicillamine; Probenecid; Sulfinpyrazone; Vasodilator Agents | 1984 |
Treatment of the gout and other forms of crystal-induced arthritis.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzbromarone; Colchicine; Gout; Gout Suppressants; Humans; Indomethacin; Kidney; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1982 |
Risks and benefits of drugs used in the management and prevention of gout.
Topics: Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Double-Blind Method; Glucocorticoids; Gout; Gout Suppressants; Humans; Probenecid; Sulfinpyrazone | 1994 |
5 trial(s) available for sulfinpyrazone and allopurinol
Article | Year |
---|---|
The effect of allopurinol (HPP) in the treatment of gout.
Topics: Clinical Trials as Topic; Enzyme Therapy; Female; Gout; Humans; Male; Sulfinpyrazone; Xanthine Oxidase | 1965 |
Comparison of allopurinol and probenecid.
Topics: Allopurinol; Clinical Trials as Topic; Colchicine; Enzyme Therapy; Follow-Up Studies; Gout; Humans; Liver Function Tests; Male; Probenecid; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
Topics: Acute Kidney Injury; Adult; Aged; Allopurinol; Arthritis, Rheumatoid; Clinical Trials as Topic; Duodenal Ulcer; Enzyme Therapy; Female; Gout; Humans; Male; Middle Aged; Psoriasis; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Effect of drugs on urate binding to plasma proteins.
Topics: Adult; Allopurinol; Arthritis; Aspirin; Blood Proteins; Chromatography, DEAE-Cellulose; Colchicine; Female; Gout; Humans; Indomethacin; Male; Phenylbutazone; Probenecid; Protein Binding; Sulfinpyrazone; Uric Acid | 1969 |
Risks and benefits of drugs used in the management and prevention of gout.
Topics: Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Double-Blind Method; Glucocorticoids; Gout; Gout Suppressants; Humans; Probenecid; Sulfinpyrazone | 1994 |
69 other study(ies) available for sulfinpyrazone and allopurinol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
[Physiopathological bases for a rational therapy of gout].
Topics: Allopurinol; Benzofurans; Gout; Humans; Life Style; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1978 |
Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
Topics: Adult; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Child; Colchicine; Drug Evaluation; Feprazone; Gout Suppressants; Humans; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone; United Kingdom | 1978 |
[The possible mechanism of action of sulfinpyrazone].
Topics: Allopurinol; Humans; Myocardial Infarction; Sulfinpyrazone | 1978 |
Management of gout.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Female; Gout; Humans; Indomethacin; Patient Education as Topic; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1979 |
The management of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Male; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone | 1979 |
Treatment of gout with alternate-day hypo-uricaemic drugs.
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Female; Gout; Humans; Male; Middle Aged; Sulfinpyrazone; Uric Acid | 1978 |
Management of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Phenylbutazone; Probenecid; Sulfinpyrazone | 1979 |
The pharmacology of the hypouricemic effect of benzbromarone.
Topics: Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Drug Interactions; Glomerular Filtration Rate; Kidney Tubules; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1977 |
[Drug therapy in uratic arthritis. II. Prevention of new attacks].
Topics: Allopurinol; Gout; Humans; Probenecid; Sulfinpyrazone | 1977 |
Drugs for gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Indomethacin; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone | 1976 |
The treatment of hyperuricemia.
Topics: Allopurinol; Drug Interactions; Drug Therapy, Combination; Humans; Phenylbutazone; Probenecid; Salicylates; Sulfinpyrazone; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1976 |
Current therapy of gout and hyperuricemia.
Topics: Allopurinol; Colchicine; Drug Interactions; Gout; Humans; Indomethacin; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
[Uricosuric agents: Should they be used in asymptomatic hyperuricemia?].
Topics: Allopurinol; Humans; Metabolic Diseases; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |
[The management of hyperuricemia associated with drug treatment of hypertension].
Topics: Acidosis; Adrenergic beta-Antagonists; Allopurinol; Antihypertensive Agents; Benzothiadiazines; Diuretics; Humans; Probenecid; Sodium Chloride Symporter Inhibitors; Sulfinpyrazone; Uric Acid | 1992 |
Dietary effects of allopurinol and sulfinpyrazone on development, survival, and reproduction of German cockroaches (Dictyoptera: Blattellidae).
Topics: Allopurinol; Animals; Cockroaches; Female; Nymph; Reproduction; Sulfinpyrazone | 1992 |
Clinical profile, therapeutic approach and outcome of gouty arthritis in northern India.
Topics: Adult; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Evaluation Studies as Topic; Humans; India; Male; Middle Aged; Patient Education as Topic; Sulfinpyrazone; Uric Acid | 1990 |
Influence of cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardial-membrane phospholipid.
Topics: Aspirin; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Humans; Indomethacin; Lipid Peroxidation; Lipid Peroxides; Lipoxygenase Inhibitors; Membrane Lipids; Myocardial Reperfusion Injury; Naproxen; Sulfinpyrazone; Superoxides; Time Factors; Xanthine Oxidase | 1989 |
Hyperuricemia and gout.
Topics: Allopurinol; Anti-Inflammatory Agents; Arthritis; Colchicine; Female; Gout; Humans; Indomethacin; Kidney Calculi; Male; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1985 |
Sulphinpyrazone dose schedule in hyperuricemic patients with cardiovascular diseases: tolerability assessment.
Topics: Allopurinol; Cardiovascular Diseases; Creatinine; Drug Tolerance; Female; Humans; Kidney Function Tests; Male; Middle Aged; Sulfinpyrazone; Uremia; Uric Acid | 1985 |
Drugs in the treatment of hyperuricemia.
Topics: Allopurinol; Gout; Humans; Oxypurinol; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1974 |
Zyloprim and other drugs in the management of gout.
Topics: Adrenocorticotropic Hormone; Colchicine; Enzyme Therapy; Enzymes; Gout; Humans; Indomethacin; Probenecid; Sulfinpyrazone; Urinary Calculi; Xanthine Oxidase | 1966 |
[The treatment of gout and the internal medical treatment of uric acid nephrolithiasis].
Topics: Adrenocorticotropic Hormone; Allopurinol; Colchicine; Gout; Humans; Indomethacin; Kidney Calculi; Prednisolone; Probenecid; Sulfinpyrazone; Uricosuric Agents | 1968 |
Recent developments in the therapy of gout.
Topics: Acute Disease; Adrenocorticotropic Hormone; Allopurinol; Analgesics; Colchicine; Gout; Humans; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1968 |
[Cutaneous side effects of systemic drugs with special reference to recently introduced medicaments. I].
Topics: Allopurinol; Analgesics; Chlorothiazide; Colchicine; Drug Eruptions; Humans; Lichen Planus; Photosensitivity Disorders; Probenecid; Quinolines; Stevens-Johnson Syndrome; Sulfinpyrazone | 1970 |
Pyrazinoate excretion in the chimpanzee. Relation to urate disposition and the actions of uricosuric drugs.
Topics: Allopurinol; Aminohippuric Acids; Animals; Biological Transport; Carboxylic Acids; Chlorothiazide; Depression, Chemical; Glomerular Filtration Rate; Insulin; Iodopyracet; Kidney Tubules; Male; Organomercury Compounds; Pan troglodytes; Probenecid; Protein Binding; Pyrazines; Salicylates; Stimulation, Chemical; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1973 |
The treatment of gout.
Topics: Acute Disease; Allopurinol; Aspirin; Colchicine; Drug Therapy, Combination; Gout; Indomethacin; Phenylbutazone; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1973 |
The binding of urate to plasma proteins.
Topics: Allopurinol; Aspirin; Binding Sites; Blood Proteins; Colchicine; Dialysis; Evaluation Studies as Topic; Gout; Humans; Hydrogen-Ion Concentration; Indomethacin; Kidney Diseases; Kinetics; Methods; Osmolar Concentration; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Solubility; Sulfinpyrazone; Temperature; Time Factors; Uric Acid | 1974 |
Medical management of gout.
Topics: Adult; Allopurinol; Colchicine; Diet Therapy; Female; Gout; Humans; Kidney Diseases; Male; Middle Aged; Oxyphenbutazone; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid | 1972 |
[Gout].
Topics: Adult; Allopurinol; Benzofurans; Colchicine; Gout; Humans; Ketones; Male; Middle Aged; Sulfinpyrazone | 1971 |
[Pharmacological studies of diuretics. 4. Changes of serum uric acid level by the succesive administration of thiazide diuretics and other drugs and effects of uricosuric drugs].
Topics: Administration, Oral; Allopurinol; Ammonium Chloride; Animals; Barbiturates; Blood Glucose; Chlorothiazide; Cyclohexanes; Diuretics; Electrolytes; Ethacrynic Acid; Glycine; Hydrochlorothiazide; Hydroflumethiazide; Injections, Subcutaneous; Male; Nucleosides; Phenylbutazone; Probenecid; Quinolines; Rats; Sulfinpyrazone; Sulfonamides; Thiadiazines; Uric Acid; Uricosuric Agents; Xanthenes | 1971 |
Allopurinol in the treatment of gout.
Topics: Adult; Aged; Allopurinol; Female; Gout; Humans; Male; Sulfinpyrazone; Uric Acid | 1969 |
[Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
Topics: Allopurinol; Diabetes Mellitus; Gout; Humans; Hypertension; Kidney Diseases; Male; Sulfinpyrazone; Uric Acid | 1969 |
Effect of drugs on the binding of urate to human albumin.
Topics: Allopurinol; Aspirin; Colchicine; Humans; Indomethacin; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sulfinpyrazone; Uric Acid | 1970 |
Long-term use of allopurinol in the treatment of gout.
Topics: Adolescent; Aged; Allopurinol; Colic; Female; Gout; Humans; Kidney Diseases; Male; Middle Aged; Sulfinpyrazone; Uric Acid | 1970 |
Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro.
Topics: Allopurinol; Anti-Inflammatory Agents; Aspirin; Binding Sites; Caprylates; Colchicine; Dialysis; Fluorescence; Humans; In Vitro Techniques; Indomethacin; Mefenamic Acid; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sodium Salicylate; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1970 |
Pathogenesis and medical management of chronic gouty arthritis.
Topics: Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Joints; Kidney; Probenecid; Sulfinpyrazone; Uric Acid | 1970 |
[Treatment of the gouty diathesis with a xanthine oxidase inhibitor. A clinical trial of allopurinol].
Topics: Aged; Allopurinol; Drug Synergism; Gout; Humans; Male; Middle Aged; Phenylbutazone; Sulfinpyrazone; Uric Acid | 1967 |
Long-term treatment of gout with "allopurinol".
Topics: Allopurinol; Chronic Disease; Colchicine; Colorimetry; Female; Gout; Humans; Male; Purines; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1968 |
Etiology and treatment of gout--modern concepts.
Topics: Allopurinol; Colchicine; Crystallization; Diagnosis, Differential; Diet Therapy; Gout; Humans; Indomethacin; Joint Diseases; Kidney Diseases; Kidneys, Artificial; Phenylbutazone; Probenecid; Proteinuria; Purines; Radiography; Salicylates; Steroids; Sulfinpyrazone; Uric Acid | 1968 |
A short trial assessment of uricosuric therapy in gout.
Topics: Adult; Aged; Allopurinol; Female; Glomerular Filtration Rate; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid | 1968 |
Pyrazolidines in the treatment of gout.
Topics: Acute Disease; Allopurinol; Anti-Inflammatory Agents; Chronic Disease; Gout; Humans; Oxyphenbutazone; Phenylbutazone; Sulfinpyrazone; Uricosuric Agents | 1968 |
[Gout in advanced age].
Topics: Age Factors; Aged; Allopurinol; Bone and Bones; Cardiovascular Diseases; Colchicine; Female; Gout; Humans; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Probenecid; Sodium; Sulfinpyrazone; Uric Acid | 1968 |
Goals in gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Probenecid; Sulfinpyrazone | 1969 |
The treatment of gout and disorders of uric acid metabolism with allopurinol.
Topics: Aged; Colchicine; Diet; Enzyme Therapy; Female; Gout; Humans; Male; Middle Aged; Sulfinpyrazone; Uric Acid; Urinary Calculi; Urobilin; Xanthine Oxidase | 1966 |
The pharmaceutical treatment of gout.
Topics: Enzyme Therapy; Gout; Humans; Indomethacin; Phenylbutazone; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Effects of allopurinol, a xanthine oxidase inhibitor, and sulfinpyrazone upon the urinary and serum urate concentrations in eight patients with tophaceous gout.
Topics: Aged; Blood; Drug Synergism; Enzyme Therapy; Gout; Humans; Middle Aged; Pyrimidines; Sulfinpyrazone; Uric Acid; Urine; Xanthine Oxidase | 1966 |
Treatment of gout by reduction of uric acid production.
Topics: Catalase; Drug Synergism; Enzyme Therapy; Gout; Humans; Kidney Calculi; Sulfinpyrazone; Uracil; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1966 |
Allopurinol (xanthine oxidase inhibitor) in the treatment of resistant gout.
Topics: Adult; Aged; Colchicine; Enzyme Therapy; Enzymes; Female; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Allopurinol in primary gout with and after the administration of uricosuric agents.
Topics: Allopurinol; Drug Synergism; Enzyme Therapy; Female; Gout; Humans; Male; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Effects of allopurinol on gouty and non-gouty uric acid nephropathy.
Topics: Allopurinol; Blood Urea Nitrogen; Enzyme Therapy; Female; Gout; Humans; Kidney Calculi; Kidney Diseases; Male; Salicylates; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1966 |
Therapy of gout.
Topics: Allopurinol; Colchicine; Gout; Humans; Phenylbutazone; Probenecid; Sulfinpyrazone | 1967 |
Allopurinol in the treatment of gout.
Topics: Allopurinol; Drug Synergism; Gout; Humans; Sulfinpyrazone | 1967 |
An approach to hyperuricemia and gout.
Topics: Allopurinol; Anti-Inflammatory Agents; Colchicine; Female; Gout; Humans; Male; Naproxen; Phenylbutazone; Prognosis; Sulfinpyrazone; Uric Acid | 1984 |
[Effect of long-term base therapy on the clinical picture of gout].
Topics: Adult; Allopurinol; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Gout; Humans; Male; Middle Aged; Probenecid; Sulfinpyrazone; Time Factors; Uric Acid | 1981 |
Sulfinpyrazone reduces cyclosporine levels: a new drug interaction in heart transplant recipients.
Topics: Allopurinol; Creatinine; Cyclosporine; Drug Interactions; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Risk Factors; Sulfinpyrazone; Urea; Uric Acid; Uricosuric Agents | 2000 |
Free radical scavenging properties of sulfinpyrazone.
Topics: Acridines; Biphenyl Compounds; Blood; Butylated Hydroxytoluene; Cell Culture Techniques; Cell-Free System; Chromans; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoresceins; Free Radical Scavengers; HL-60 Cells; Humans; Inhibitory Concentration 50; Luminescent Measurements; Picrates; Sulfinpyrazone; Tetradecanoylphorbol Acetate; Xanthine Oxidase | 2002 |
THE RENAL EXCRETION OF OXYPURINES.
Topics: Enzyme Inhibitors; Fluids and Secretions; Gout; Hypoxanthines; Kidney; Pharmacology; Physiology; Probenecid; Purines; Pyrimidines; Renal Elimination; Salicylates; Spectrophotometry; Sulfinpyrazone; Uricosuric Agents; Urine; Xanthine Oxidase; Xanthines | 1965 |
Uric acid lowering therapy: prescribing patterns in a large cohort of older adults.
Topics: Age Factors; Aged; Aged, 80 and over; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Black or African American; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Humans; Logistic Models; Male; Massachusetts; Patient Compliance; Probenecid; Sulfinpyrazone; White People | 2008 |
Adherence with urate-lowering therapies for the treatment of gout.
Topics: Age Factors; Allopurinol; Female; Gout; Gout Suppressants; Humans; Male; Medication Adherence; Middle Aged; Probenecid; Sulfinpyrazone; Uric Acid | 2009 |
Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Allopurinol; Animals; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Drug Administration Schedule; Flavanones; Homovanillic Acid; Infusions, Parenteral; Male; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neurotoxins; Oxidative Stress; Parkinson Disease; Silymarin; Sulfinpyrazone; Uric Acid | 2013 |
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.
Topics: Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; British Columbia; Colchicine; Comorbidity; Diabetes Mellitus; Febuxostat; Female; Glucocorticoids; Gout; Gout Suppressants; Humans; Hyperlipidemias; Hypertension; Incidence; Male; Middle Aged; Population Growth; Prevalence; Probenecid; Sulfinpyrazone; Uricosuric Agents | 2017 |